Cargando…

SAT-447 Diminished Pituitary Volume May be Linked to Short Stature in Patients with Noonan Syndrome

Background: We have previously demonstrated that short children with Idiopathic Short Stature (ISS), Growth Hormone Deficiency (GHD), and their short siblings have significantly diminished pituitary volumes (PV) compared to normal children. In comparison, patients with Turner syndrome have not been...

Descripción completa

Detalles Bibliográficos
Autores principales: Potenza, Robert, Benn, Max, El-Naghy, Zeyad, McGuirk, Liam, Patale, Tara, Krasnow, Nicholas, Weiler, Winston, Haigney, James, Thompson, Carl, Tenner, Michael, Romano, Alicia, Noto, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552469/
http://dx.doi.org/10.1210/js.2019-SAT-447
_version_ 1783424599300505600
author Potenza, Robert
Benn, Max
El-Naghy, Zeyad
McGuirk, Liam
Patale, Tara
Krasnow, Nicholas
Weiler, Winston
Haigney, James
Thompson, Carl
Tenner, Michael
Romano, Alicia
Noto, Richard
author_facet Potenza, Robert
Benn, Max
El-Naghy, Zeyad
McGuirk, Liam
Patale, Tara
Krasnow, Nicholas
Weiler, Winston
Haigney, James
Thompson, Carl
Tenner, Michael
Romano, Alicia
Noto, Richard
author_sort Potenza, Robert
collection PubMed
description Background: We have previously demonstrated that short children with Idiopathic Short Stature (ISS), Growth Hormone Deficiency (GHD), and their short siblings have significantly diminished pituitary volumes (PV) compared to normal children. In comparison, patients with Turner syndrome have not been found to manifest this finding. We speculate that pituitary hypoplasia may also contribute to short stature in Noonan syndrome (NS) patients. Objective: To compare pituitary volumes between normal children and children with Noonan syndrome. Patients and Methods: A retrospective chart review for NS patients from 2010-16 between the ages of 3-11.5 yrs who underwent a high resolution post-contrast MRI (1 mm slices) was undertaken. 8 patients were identified. 4 of the patients had the PTPN11 gene mutation and formed the P1 group. The other 4 NS patients lacked confirmed PTPN11 mutations. High resolution post-contrast MRIs (1 mm slices) from years 1999-06 in children aged 3-11.5 yrs with seizures and headaches without major pathologic findings were reviewed. 31 children met these criteria and formed the control group. PV was evaluated using the ellipsoid formula (LxWxH/2). The wilcoxon rank sum test was used to compare means of non-parametric data between 2 groups, and a Kruskall-Wallis was used to compare means of non-parametric data between multiple groups in NCSS12. Results: The mean and median age for NS children was 7.92±3.22 yrs and 8.86 yrs, respectively. The mean and median age for the P1 group was 7.04±3.09 yrs and 6.27 yrs, and the mean and median age for the other NS group was 8.81±3.53 yrs and 10.21 yrs. The mean and median age for controls was 6.88±2.70 yrs and 7.08 yrs, respectively. The difference in age between all groups was not significant (p=0.23). Mean and median PV for the NS children were 205.74±52.81 mm3 and 178 mm3 respectively. The mean and median PV for the controls were 294.71±93.85 mm3 and 276.27 mm3, respectively. Mean and median PV for the P1 group was 182±19.40 mm3 and 175 mm3, and the mean and median PV for the other NS group was 229.49±68.03 mm3 and 228.48 mm3. Differences in PV between controls, P1, and other NS was significant (p=0.02). The difference in PV of controls versus P1 was significant (p=0.01). The difference in PV of controls versus all NS patients was significant (p=0.01). The difference between the PV of controls and other NS patients was not significant (p=0.28). The difference between the PV of P1 and other NS patients was not significant (p=0.56). Conclusion: These data suggest that NS patients have significantly lower PV compared to controls, particularly those with the PTPN11 mutation. Our previous work has demonstrated an association between diminished PV, GHD, and ISS. We hypothesize that the diminished PV may be in part responsible for short stature in NS as well. WE SEEK COLLABORATION WITH OTHER INVESTIGATORS TO FURTHER EXPLORE THIS HYPOTHESIS.
format Online
Article
Text
id pubmed-6552469
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65524692019-06-13 SAT-447 Diminished Pituitary Volume May be Linked to Short Stature in Patients with Noonan Syndrome Potenza, Robert Benn, Max El-Naghy, Zeyad McGuirk, Liam Patale, Tara Krasnow, Nicholas Weiler, Winston Haigney, James Thompson, Carl Tenner, Michael Romano, Alicia Noto, Richard J Endocr Soc Neuroendocrinology and Pituitary Background: We have previously demonstrated that short children with Idiopathic Short Stature (ISS), Growth Hormone Deficiency (GHD), and their short siblings have significantly diminished pituitary volumes (PV) compared to normal children. In comparison, patients with Turner syndrome have not been found to manifest this finding. We speculate that pituitary hypoplasia may also contribute to short stature in Noonan syndrome (NS) patients. Objective: To compare pituitary volumes between normal children and children with Noonan syndrome. Patients and Methods: A retrospective chart review for NS patients from 2010-16 between the ages of 3-11.5 yrs who underwent a high resolution post-contrast MRI (1 mm slices) was undertaken. 8 patients were identified. 4 of the patients had the PTPN11 gene mutation and formed the P1 group. The other 4 NS patients lacked confirmed PTPN11 mutations. High resolution post-contrast MRIs (1 mm slices) from years 1999-06 in children aged 3-11.5 yrs with seizures and headaches without major pathologic findings were reviewed. 31 children met these criteria and formed the control group. PV was evaluated using the ellipsoid formula (LxWxH/2). The wilcoxon rank sum test was used to compare means of non-parametric data between 2 groups, and a Kruskall-Wallis was used to compare means of non-parametric data between multiple groups in NCSS12. Results: The mean and median age for NS children was 7.92±3.22 yrs and 8.86 yrs, respectively. The mean and median age for the P1 group was 7.04±3.09 yrs and 6.27 yrs, and the mean and median age for the other NS group was 8.81±3.53 yrs and 10.21 yrs. The mean and median age for controls was 6.88±2.70 yrs and 7.08 yrs, respectively. The difference in age between all groups was not significant (p=0.23). Mean and median PV for the NS children were 205.74±52.81 mm3 and 178 mm3 respectively. The mean and median PV for the controls were 294.71±93.85 mm3 and 276.27 mm3, respectively. Mean and median PV for the P1 group was 182±19.40 mm3 and 175 mm3, and the mean and median PV for the other NS group was 229.49±68.03 mm3 and 228.48 mm3. Differences in PV between controls, P1, and other NS was significant (p=0.02). The difference in PV of controls versus P1 was significant (p=0.01). The difference in PV of controls versus all NS patients was significant (p=0.01). The difference between the PV of controls and other NS patients was not significant (p=0.28). The difference between the PV of P1 and other NS patients was not significant (p=0.56). Conclusion: These data suggest that NS patients have significantly lower PV compared to controls, particularly those with the PTPN11 mutation. Our previous work has demonstrated an association between diminished PV, GHD, and ISS. We hypothesize that the diminished PV may be in part responsible for short stature in NS as well. WE SEEK COLLABORATION WITH OTHER INVESTIGATORS TO FURTHER EXPLORE THIS HYPOTHESIS. Endocrine Society 2019-04-30 /pmc/articles/PMC6552469/ http://dx.doi.org/10.1210/js.2019-SAT-447 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Neuroendocrinology and Pituitary
Potenza, Robert
Benn, Max
El-Naghy, Zeyad
McGuirk, Liam
Patale, Tara
Krasnow, Nicholas
Weiler, Winston
Haigney, James
Thompson, Carl
Tenner, Michael
Romano, Alicia
Noto, Richard
SAT-447 Diminished Pituitary Volume May be Linked to Short Stature in Patients with Noonan Syndrome
title SAT-447 Diminished Pituitary Volume May be Linked to Short Stature in Patients with Noonan Syndrome
title_full SAT-447 Diminished Pituitary Volume May be Linked to Short Stature in Patients with Noonan Syndrome
title_fullStr SAT-447 Diminished Pituitary Volume May be Linked to Short Stature in Patients with Noonan Syndrome
title_full_unstemmed SAT-447 Diminished Pituitary Volume May be Linked to Short Stature in Patients with Noonan Syndrome
title_short SAT-447 Diminished Pituitary Volume May be Linked to Short Stature in Patients with Noonan Syndrome
title_sort sat-447 diminished pituitary volume may be linked to short stature in patients with noonan syndrome
topic Neuroendocrinology and Pituitary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552469/
http://dx.doi.org/10.1210/js.2019-SAT-447
work_keys_str_mv AT potenzarobert sat447diminishedpituitaryvolumemaybelinkedtoshortstatureinpatientswithnoonansyndrome
AT bennmax sat447diminishedpituitaryvolumemaybelinkedtoshortstatureinpatientswithnoonansyndrome
AT elnaghyzeyad sat447diminishedpituitaryvolumemaybelinkedtoshortstatureinpatientswithnoonansyndrome
AT mcguirkliam sat447diminishedpituitaryvolumemaybelinkedtoshortstatureinpatientswithnoonansyndrome
AT pataletara sat447diminishedpituitaryvolumemaybelinkedtoshortstatureinpatientswithnoonansyndrome
AT krasnownicholas sat447diminishedpituitaryvolumemaybelinkedtoshortstatureinpatientswithnoonansyndrome
AT weilerwinston sat447diminishedpituitaryvolumemaybelinkedtoshortstatureinpatientswithnoonansyndrome
AT haigneyjames sat447diminishedpituitaryvolumemaybelinkedtoshortstatureinpatientswithnoonansyndrome
AT thompsoncarl sat447diminishedpituitaryvolumemaybelinkedtoshortstatureinpatientswithnoonansyndrome
AT tennermichael sat447diminishedpituitaryvolumemaybelinkedtoshortstatureinpatientswithnoonansyndrome
AT romanoalicia sat447diminishedpituitaryvolumemaybelinkedtoshortstatureinpatientswithnoonansyndrome
AT notorichard sat447diminishedpituitaryvolumemaybelinkedtoshortstatureinpatientswithnoonansyndrome